Results for tag: "Cholesterol Management"

The Cholesterol Management market within the context of Cardiovascular Devices is a rapidly growing sector of the medical device industry. It includes products and services that are used to diagnose, treat, and monitor cholesterol levels in patients. These products range from diagnostic tests to drug therapies and lifestyle modifications. The goal of cholesterol management is to reduce the risk of cardiovascular disease, which is the leading cause of death worldwide. The market is driven by the increasing prevalence of cardiovascular diseases, the growing awareness of cholesterol-related health risks, and the availability of new technologies. Additionally, the increasing demand for personalized healthcare solutions and the growing focus on preventive healthcare are expected to drive the market growth. Some of the major companies in the Cholesterol Management market include Abbott Laboratories, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more